Pfizer Inc.
PFE
$24.86
$0.291.18%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
06/29/2025 | 03/30/2025 | 12/31/2024 | 09/29/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 10.31% | -7.82% | 21.92% | 31.20% | 2.13% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 10.31% | -7.82% | 21.92% | 31.20% | 2.12% |
Cost of Revenue | 26.52% | -14.62% | 438.65% | -45.30% | -9.90% |
Gross Profit | 6.05% | -6.07% | -10.97% | 179.70% | 5.84% |
SG&A Expenses | -7.45% | -13.08% | 14.75% | 0.13% | 6.75% |
Depreciation & Amortization | -7.35% | -7.42% | 7.26% | 11.28% | 10.39% |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 1.36% | -12.58% | 60.03% | -25.28% | 0.89% |
Operating Income | 41.37% | 2.49% | -46.04% | 344.64% | 6.64% |
Income Before Tax | 3,055.34% | -18.62% | 99.76% | 240.66% | -104.54% |
Income Tax Expenses | 205.22% | -164.51% | 47.04% | 124.27% | -88.73% |
Earnings from Continuing Operations | 9,264.52% | -4.96% | 112.33% | 287.65% | -98.68% |
Earnings from Discontinued Operations | 47.06% | -- | 126.92% | -166.67% | 950.00% |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -157.14% | 25.00% | 11.11% | -33.33% | 36.36% |
Net Income | 6,997.56% | -4.75% | 112.17% | 287.45% | -98.24% |
EBIT | 41.37% | 2.49% | -46.04% | 344.64% | 6.64% |
EBITDA | 23.94% | -0.02% | -33.15% | 1,012.64% | 7.90% |
EPS Basic | 7,009.72% | -5.05% | 112.12% | 286.75% | -98.25% |
Normalized Basic EPS | 50.13% | 9.26% | -56.50% | 329.71% | -14.03% |
EPS Diluted | 7,009.72% | -5.30% | 111.86% | 286.75% | -98.24% |
Normalized Diluted EPS | 50.36% | 9.35% | -56.79% | 328.15% | -13.48% |
Average Basic Shares Outstanding | 0.34% | 0.32% | 0.35% | 0.37% | 0.35% |
Average Diluted Shares Outstanding | 0.18% | 0.23% | 0.99% | 1.04% | -0.30% |
Dividend Per Share | 2.38% | 2.38% | 2.44% | 2.44% | 2.44% |
Payout Ratio | -- | 0.08% | 9.45% | 1.55% | 57.35% |